These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 26134112

  • 1. Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.
    Lemoine L, Saint-Aubert L, Marutle A, Antoni G, Eriksson JP, Ghetti B, Okamura N, Nennesmo I, Gillberg PG, Nordberg A.
    Acta Neuropathol Commun; 2015 Jul 02; 3():40. PubMed ID: 26134112
    [Abstract] [Full Text] [Related]

  • 2. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
    Lemoine L, Gillberg PG, Svedberg M, Stepanov V, Jia Z, Huang J, Nag S, Tian H, Ghetti B, Okamura N, Higuchi M, Halldin C, Nordberg A.
    Alzheimers Res Ther; 2017 Dec 11; 9(1):96. PubMed ID: 29229003
    [Abstract] [Full Text] [Related]

  • 3. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
    Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Tago T, Hiraoka K, Watanuki S, Shidahara M, Miyake M, Ishikawa Y, Matsuda R, Inami A, Yoshikawa T, Funaki Y, Iwata R, Tashiro M, Yanai K, Arai H, Kudo Y.
    J Nucl Med; 2016 Feb 11; 57(2):208-14. PubMed ID: 26541774
    [Abstract] [Full Text] [Related]

  • 4. Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography.
    Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg PG, Nordberg A.
    Sci Rep; 2017 Apr 04; 7():45496. PubMed ID: 28374768
    [Abstract] [Full Text] [Related]

  • 5. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
    Okamura N, Furumoto S, Harada R, Tago T, Yoshikawa T, Fodero-Tavoletti M, Mulligan RS, Villemagne VL, Akatsu H, Yamamoto T, Arai H, Iwata R, Yanai K, Kudo Y.
    J Nucl Med; 2013 Aug 04; 54(8):1420-7. PubMed ID: 23857514
    [Abstract] [Full Text] [Related]

  • 6. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases.
    Malarte ML, Nordberg A, Lemoine L.
    Eur J Nucl Med Mol Imaging; 2021 Apr 04; 48(4):1093-1102. PubMed ID: 32970217
    [Abstract] [Full Text] [Related]

  • 7. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.
    Lemoine L, Ledreux A, Mufson EJ, Perez SE, Simic G, Doran E, Lott I, Carroll S, Bharani K, Thomas S, Gilmore A, Hamlett ED, Nordberg A, Granholm AC.
    Mol Neurodegener; 2020 Nov 23; 15(1):68. PubMed ID: 33222700
    [Abstract] [Full Text] [Related]

  • 8. Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models.
    Brendel M, Jaworska A, Probst F, Overhoff F, Korzhova V, Lindner S, Carlsen J, Bartenstein P, Harada R, Kudo Y, Haass C, Van Leuven F, Okamura N, Herms J, Rominger A.
    J Nucl Med; 2016 May 23; 57(5):792-8. PubMed ID: 26912432
    [Abstract] [Full Text] [Related]

  • 9. Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.
    Cai L, Qu B, Hurtle BT, Dadiboyena S, Diaz-Arrastia R, Pike VW.
    ACS Chem Neurosci; 2016 Jul 20; 7(7):897-911. PubMed ID: 27171905
    [Abstract] [Full Text] [Related]

  • 10. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson J, Sörensen J, Antoni G, Nordberg A, Lubberink M.
    J Nucl Med; 2016 Apr 20; 57(4):574-81. PubMed ID: 26795290
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vivo quantification of neurofibrillary tangles with [18F]MK-6240.
    Pascoal TA, Shin M, Kang MS, Chamoun M, Chartrand D, Mathotaarachchi S, Bennacef I, Therriault J, Ng KP, Hopewell R, Bouhachi R, Hsiao HH, Benedet AL, Soucy JP, Massarweh G, Gauthier S, Rosa-Neto P.
    Alzheimers Res Ther; 2018 Jul 31; 10(1):74. PubMed ID: 30064520
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
    Xia CF, Arteaga J, Chen G, Gangadharmath U, Gomez LF, Kasi D, Lam C, Liang Q, Liu C, Mocharla VP, Mu F, Sinha A, Su H, Szardenings AK, Walsh JC, Wang E, Yu C, Zhang W, Zhao T, Kolb HC.
    Alzheimers Dement; 2013 Nov 31; 9(6):666-76. PubMed ID: 23411393
    [Abstract] [Full Text] [Related]

  • 18. Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
    Yousefi BH, Manook A, Grimmer T, Arzberger T, von Reutern B, Henriksen G, Drzezga A, Förster S, Schwaiger M, Wester HJ.
    ACS Chem Neurosci; 2015 Mar 18; 6(3):428-37. PubMed ID: 25482310
    [Abstract] [Full Text] [Related]

  • 19. Preclinical Evaluation of [(18)F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer.
    Tago T, Furumoto S, Okamura N, Harada R, Adachi H, Ishikawa Y, Yanai K, Iwata R, Kudo Y.
    Mol Imaging Biol; 2016 Apr 18; 18(2):258-66. PubMed ID: 26194011
    [Abstract] [Full Text] [Related]

  • 20. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9.
    Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, Graff C, Ingelsson M, Nordberg A.
    Mol Psychiatry; 2021 Oct 18; 26(10):5609-5619. PubMed ID: 32581318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.